Upregulation of the creatine transporter Slc6A8 by Klotho

Kidney Blood Press Res. 2014;39(6):516-25. doi: 10.1159/000368462. Epub 2014 Nov 29.

Abstract

Background/aims: The transmembrane Klotho protein contributes to inhibition of 1,25(OH)2D3 formation. The extracellular domain of Klotho protein could function as an enzyme with e.g. β-glucuronidase activity, be cleaved off and be released into blood and cerebrospinal fluid. Klotho regulates several cellular transporters. Klotho protein deficiency accelerates the appearance of age related disorders including neurodegeneration and muscle wasting and eventually leads to premature death. The main site of Klotho protein expression is the kidney. Klotho protein is also appreciably expressed in other tissues including chorioid plexus. The present study explored the effect of Klotho protein on the creatine transporter CreaT (Slc6A8), which participates in the maintenance of neuronal function and survival.

Methods: To this end cRNA encoding Slc6A8 was injected into Xenopus oocytes with and without additional injection of cRNA encoding Klotho protein. Creatine transporter CreaT (Slc6A8) activity was estimated from creatine induced current determined by two-electrode voltage-clamp.

Results: Coexpression of Klotho protein significantly increased creatine-induced current in Slc6A8 expressing Xenopus oocytes. Coexpression of Klotho protein delayed the decline of creatine induced current following inhibition of carrier insertion into the cell membrane by brefeldin A (5 µM). The increase of creatine induced current by coexpression of Klotho protein in Slc6A8 expressing Xenopus oocytes was reversed by β-glucuronidase inhibitor (DSAL). Similarly, treatment of Slc6A8 expressing Xenopus oocytes with recombinant human alpha Klotho protein significantly increased creatine induced current.

Conclusion: Klotho protein up-regulates the activity of creatine transporter CreaT (Slc6A8) by stabilizing the carrier protein in the cell membrane, an effect requiring β-glucuronidase activity of Klotho protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cell Survival / genetics
  • Enzyme Inhibitors / therapeutic use
  • Glucuronidase / antagonists & inhibitors
  • Glucuronidase / genetics
  • Glucuronidase / physiology*
  • Glycoproteins
  • Humans
  • Klotho Proteins
  • Nerve Tissue Proteins / biosynthesis*
  • Nerve Tissue Proteins / genetics
  • Neurons
  • Oocytes
  • Patch-Clamp Techniques
  • Plasma Membrane Neurotransmitter Transport Proteins / biosynthesis*
  • Plasma Membrane Neurotransmitter Transport Proteins / genetics
  • RNA, Complementary / biosynthesis
  • RNA, Complementary / genetics
  • Up-Regulation
  • Xenopus

Substances

  • Enzyme Inhibitors
  • Glycoproteins
  • Nerve Tissue Proteins
  • Plasma Membrane Neurotransmitter Transport Proteins
  • RNA, Complementary
  • SLC6A8 protein, human
  • beta-glucuronidase inhibitor
  • Glucuronidase
  • Klotho Proteins